Running Point Capital Advisors, LLC Gilead Sciences, Inc. Transaction History
Running Point Capital Advisors, LLC
- $305 Million
- Q1 2025
A detailed history of Running Point Capital Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Running Point Capital Advisors, LLC holds 1,894 shares of GILD stock, worth $207,071. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,894Holding current value
$207,071% of portfolio
0.07%Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,286Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.8 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.51 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.97 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.85 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $137B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...